Living with neovascular age-related macular degeneration (nAMD) can be challenging. You are not alone. Millions of people share your journey, navigating the uncertainties of treatment and the hope of preserving their vision. We believe that informed patients are empowered patients. That's why we want to introduce you to deepeye® TPS, an advanced AI technology that supports your ophthalmologist in planning the best possible care for you.
Managing nAMD often involves a cycle of clinic visits and eye injections, which can be demanding. Real-world studies show that many patients struggle to keep up with their treatment schedules. In fact, after two years, over 60% of patients have difficulty continuing their therapy, which can unfortunately lead to permanent vision loss.
This can be due to many factors:
Wondering if the treatment is working.
The stress and time commitment of frequent appointments.
The constant worry about the future of your vision.
Imagine if your doctor had an expert-level assistant available 24/7 to help analyze your eye scans.
That's deepeye TPS (Therapy Planning Support).
It is a certified medical device that uses artificial intelligence to provide your ophthalmologist with a digital second opinion. It doesn't just look at biomarkers; it analyzes your OCT eye scans and compares them to tens of thousands of similar cases to find patterns that might be invisible to the human eye.
This allows the AI to:
with great precision
over the next 12 months
in creating a truly personalized therapy plan.
When your doctor uses deepeye® TPS, it opens up a new level of personalized care, focused on achieving the best possible results for you
A similar approach of "double reading" OCT scans in a large German study showed that patients achieved up to 3 times higher vision gains compared to standard real-world outcomes.
The system helps answer the common patient question, "What happens next?" by providing a forecast of your future treatment needs. This clarity can help you and your doctor plan ahead with confidence.
By visualizing your progress and future path, deepeye® TPS becomes a powerful tool for patient education. Studies show that patients who have this level of support are twice as likely to stick with their therapy, which is critical for long-term success
Integrating deepeye® TPS into your regular appointment is simple and requires no extra steps from you.
Your ophthalmologist or their assistant performs your routine OCT scan, a quick and painless imaging test.
With one click, the scan is securely and anonymously sent to the AI for analysis. Your privacy is always protected.
Within m, your doctor receives a detailed report with easy-to-understand graphs showing your disease progression and a prediction of future needs. They can then discuss these insights with you.
"For the first time, the deepeye solution enables a needs-oriented, patient-specific treatment strategy."
Prof. Albrecht Lommatzsch
"I was very surprised myself at how simple and concrete the result is. We can very concretely read out disease activity and perhaps also prognosis."
Prof. Nikolaus Feucht
"I don’t need AI to recognize nAMD. I need deepeye to predict my patients’ disease progression."
Prof. Clemens Lange
You are the most important member of your care team.
An informed conversation with your doctor is the best first step toward a more predictable and confident treatment journey.
